Skip to main content
Log in

Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

In the present report, we retrospectively analyzed the impact of the timing of surgery during menstrual cycle on disease‐free and overall survival of 248 premenopausal patients with stage I/Il breast cancer who underwent surgery followed by anthracycline‐containing adjuvant chemotherapy. With a median follow‐up of 5 years, no statistically significant differences were observed in disease‐free or overall survival between women operated upon during the follicular (days 0–14) and the luteal (days 15–32) phase of the menstrual cycle. The impact on disease‐free and overall survival of lymph‐node status, tumor size and hormone receptor expression, but not of the phase of the menstrual cycle at the time of surgery, was confirmed by univariate and multivariate analysis.

However, when combined with hormone receptor status, the phase of the menstrual cycle at the time of surgery proved useful to better define the prognosis of primary breast cancer patients, with significantly longer disease‐free and overall survival for patients operated upon during the follicular phase and with positive hormone receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Senie RT, Tenser SM: The timing of breast cancer surgery during the menstrual cycle. Oncology 11: 1509-1517, 1997

    Google Scholar 

  2. Masters JRW, Drife JO, Scarisbrick JJ: Cyclic variation in DNA synthesis in human breast epithelium. J Natl Cancer Inst 58: 1263-1265, 1977

    Google Scholar 

  3. Anderson TJ: Mitotic activity in the breast. Obstet Gynecol (suppl 2)4: S114-S118, 1984

    Google Scholar 

  4. Hrushesky WJ, Gruber SA, Sothern RB, Hoffman RA, Lakatua D, Carlson A, Cerra F, Simmons RL: Natural killer cell activity: age, estrous-and circadian-stage dependence and inverse correlation with metastatic potential. J NatI Cancer Inst 80: 1232-1237, 1988

    Google Scholar 

  5. Hrushesky WJ, Bluming AZ, Gruber SA, Sothern RB: Menstrual influence on surgical cure of breast cancer. Lancet 2: 949-952, 1989

    Google Scholar 

  6. Senie RT, Kinne DW: Menstrual timing of treatment for breast cancer. J NatI Cancer Inst Monographs 16: 85-90, 1994

    Google Scholar 

  7. Fentiman IS, Gregory WM, Richards MA: Effect of menstrual phase on surgical treatment of breast cancer. Lancet 344: 402-404, 1994

    Google Scholar 

  8. Papaldo P, Lopez M, Cortesi E, Foggi CM, Antimi M, Lepidini G, Terzoli E, Nisticò C, Vici P, Conti F, D'Ottavio AM, Vaccaro A, Giannarelli D, Calabresi F: Adjuvant epirubicin and cyclophosphamide (EC) ± lonidamine (L) ± G-CSF (G) in 506 stage I–II breast cancer patients (pts): 5-year results of a multicentric randomized phase Ill trial (Abstract). Proc Am Soc Clin Oncol 17: 448, 1998

    Google Scholar 

  9. Sainsbury R, Jones M, Parker D, Hall R, Close H: Timing of surgery for breast cancer and menstrual cycle. Lancet 338: 391-392, 1992

    Google Scholar 

  10. Badwe RA, Gregory WM, Chaudary MA, Richards MA, Bentley AE, Rubens RD, Fentiman IS: Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet 337: 1261-1264, 1991

    Google Scholar 

  11. Kurebayashi J, Sonoo H, Shimozuma K: Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer. Jpn J Surg 25: 519-524, 1995

    Google Scholar 

  12. Mohr PE, Wang DY, Gregory WM, Richards MA, Fentiman IS: Serum progesterone and prognosis in operable breast cancer. Br J Cancer 73: 1552-1555, 1996

    Google Scholar 

  13. Spratt JS, Zirnheld J, Yancey JM: Breast cancer detection demonstration project data can determine whether the prognosis of breast cancer is affected by the time of surgery during the menstrual cycle. J Surg Oncol 53: 4-9, 1993

    Google Scholar 

  14. Senie RT, Rosen PP, Rhodes P, Lesser ML: Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Intern Med 115(5): 337-342, 1991

    Google Scholar 

  15. Davidson NE, Abeloff MD: Menstrual effects on surgical treatment for breast cancer. Cancer Treat Rev 19: 105-112, 1993

    Google Scholar 

  16. Hines OJ, Love SM: Should we schedule breast surgery based on a woman's menstrual cycle? Breast J 1: 173-179, 1995

    Google Scholar 

  17. McGuire WL: The optimal timing of mastectomy: low tide or high tide? Ann Intern Med 115: 401-403, 1991

    Google Scholar 

  18. Powles TJ, Ashley SE, Nash AG, Tidy A, Gazet J-C, Ford HT: Timing of surgery in breast cancer (letter). Lancet 337: 1604, 1991

    Google Scholar 

  19. Ville Y, Briere M, Lasry S, Spyratos F, Oglobine J, Brunet M: Timing of surgery in breast cancer. Lancet 337: 1604-1605, 1991

    Google Scholar 

  20. Rageth JC, Wyss P, Unger C, Hochuli E: Timing of breast cancer surgery within the menstrual cycle: influence on lymph-node involvement, receptor status, postoperative metastatic spread and local recurrence. Ann Oncol 2: 269-272, 1991

    Google Scholar 

  21. Donegan WL, Shah D: Prognosis of patients with breast cancer related to the timing of operation. Arch Surg 128: 309-313, 1993

    Google Scholar 

  22. Sigurdsson H, Baldetorp B, Borg A, Fernö M, Ingvar C, Olsson H, Olsson PO, and Killander D: Timing of surgery in the menstrual cycle does not appear to be a significant determinant of outcome in primary breast cancer (Abstract). Proc Am Soc Clin Oncol 11: 73, 1992

    Google Scholar 

  23. Jager W, Sauerbrei W: Effect of timing of surgery during menstrual cycle of premenopausal breast cancer patients. Breast Cancer Res Treat 34: 279-287, 1995

    Google Scholar 

  24. Senie RT, Rosen PP, Rhodes P, Lesser ML: Prognosis of primary breast cancer patients in relation to time of diagnostic surgery during the menstrual cycle (Abstract). Breast Cancer Res Treat 16: 146, 1990

    Google Scholar 

  25. Veronesi U, Luini A, Mariani L: Effect of menstrual phase on surgical treatment of breast cancer. Lancet 343: 1545-1547, 1994

    Google Scholar 

  26. Saad Z, Bramwell V, Duff J, Girotti M, Jory T, Heathcote G, Turnbull I, Garcia B, Stitt L: Timing of surgery in relation to the menstrual cycle in premenopausal women with operable breast cancer. Br J Surg 81: 217-220, 1994

    Google Scholar 

  27. Harlap S, Zauber AG, Pollack DM, Tang J, Arena AE, Sternfels P, Borgen P, Norton L: Survival of premenopausal women with breast carcinoma: effects of menstrual timing of surgery. Cancer 83: 76-88, 1998

    Google Scholar 

  28. Tempfer C, Haeusler G, Heinzl H, KoIb R, Hanzal E, Kainz Ch: Menstrual phase and breast cancer surgery: influence on clinical outcome or pitfall of statistical analysis? Cancer Lett 110: 145-148, 1996

    Google Scholar 

  29. Mènard S, Casalini P, Agresti R, Pilotti S, Balsari A: Proliferation of breast carcinoma during menstrual phases. Lancet 352: 148-149, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milella, M., Nisticò, C., Ferraresi, V. et al. Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women. Breast Cancer Res Treat 55, 259–266 (1999). https://doi.org/10.1023/A:1006276120841

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006276120841

Navigation